Bashkiria residents will be able to be vaccinated with CoviVac of Chumakov Center

IMPORT Сервисный

In the near future, residents of Bashkiria will be able to be vaccinated with CoviVac drug produced by the M. P. Chumakov Moscow Scientific Center for Research and Development of Immunobiological Preparations. This was stated at a weekly briefing session in the government by the Minister of Health of Bashkiria, Maxim Zabelin.

According to him, within three to five days, about 16 thousand doses of the vaccine will arrive in Bashkiria, including the third Russian vaccine against the coronavirus CoviVac of the Chumakov Center.

"Thus, we will have experience of working with three Russian vaccines," the Minister of Health noted.

As of May 17, Bashkiria received 367,834 doses of the Gam-COVID-Vac and EpiVacCorona vaccines. 224 860 people completed the vaccination, that is, 62% of the received vaccines, 310 496 people jabbed the first dose of the vaccine.

In total, to date, 36,950 residents of the republic have been infected with the new coronavirus, 90 of them in the last 24 hours.

The CoviVac vaccine from the Chumakov Center of the Russian Academy of Sciences is based on the inactivated SARS-CoV-2 virus. The immunogenicity of this vaccine is estimated to be 85 percent.

#covivac #vaccine

Join us for more and faster updates on our social media.:

Rubrics

Phone

Office: +7(347) 250-05-07 Advertising office: +7(347) 250-11-11 Editors office: +7(347) 250-07-28 Cooperation: +7(347) 250-06-14

inf@bashinform.ru

Address

450077, Ufa, Kirov street, 45

© 1992-2026 Bashinform News Agency JSC. Mass Media Registration Certificate No. TU 02-01609 dated September 25, 2017, issued by the Office of the Federal Service for Supervision of Communications, Information Technology and Mass Media for the Republic of Bashkortostan.

All information and content posted on the website www.bashinform.ru are protected by international and Russian copyright and related rights legislation. All reports by the Bashinform News Agency are intended for users over 18 years of age.

When reprinting or quoting, a reference to Bashinform News Agency is mandatory. For online publications and social media, a direct active hyperlink is required. Using the Bashinform News Agency logo for purposes not related to the agency when reprinting or quoting is permitted only with the written permission of JSC Bashinform News Agency.